You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 2019020
Jan 2020020
Feb 2020010
Mar 2020010
Apr 2020040
Jun 2020090
Jul 2020040
Aug 2020010
Sep 2020040
Oct 2020010
Nov 2020020
Dec 2020010
Feb 2021020
Apr 2021020
Jun 2021010
Sep 2021020
Oct 2021021
Nov 2021055
Dec 2021051
Jan 2022040
Feb 2022010
Mar 2022030
Apr 2022010
May 2022050
Jun 2022020
Jul 2022051
Aug 2022053
Sep 2022070
Oct 2022040
Nov 2022040
Dec 2022050
Jan 2023010
Feb 2023030
Mar 2023010
Apr 2023030
May 2023020
Jun 2023021
Jul 2023011
Sep 2023020
Oct 2023031
Nov 2023052
Dec 2023090
Jan 2024030
Feb 2024031
Mar 20240461
Apr 20240110
May 2024054
Jun 2024020
Jul 2024062
Aug 2024031
Total015695